维普中文期刊产品整合服务
27篇 您的检索式:作者名="BRAMLAGE C P"
    题名 作者 年代 出处 被引量
1Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proaf-of-eoncept study显示文摘Schindler C Mueller A Bramlage P 2007Angiology2007,58,6:1
2Role of the vasodilator peptide angiotensin-( 1-7 ) in cardiovascular drug therapy显示文摘Schindler C Bramlage P Kirch W Ferrario C M 2007Vasc Health Risk Manag2007,3,:1
3Diabetes treatment patterns and goal achievement in primary diabetes care ( DiaRegis )-study protocol and patient characteristics at baseline显示文摘Bramlage P Binz C Gitt AK 2010Cardiovasc Diabetol2010,53,9:1
4Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium显示文摘BRAMLAGE C P KAPS C UNGETHUM U 2008Scand J Rheumatol2008,37,6:1
5Prevalence of obesity in primary care using different anthropometric measures results of the German Metabolic and Cardiovascular Risk Project(GEMCAS)显示文摘Hauner H Bramlage P Losch C 2008BMC Public Health2008,8,:1
6Aotidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients-an analysis &the diaregis registry显示文摘Tschope D Bramlage P Binz C 2011Cardiovasc Diabetol2011,10,:1
7Differences in pharmacology and their translation into differences in clinical efficacy-a comparison of the rennin angiotensin blocking agents irbesartan and losartan显示文摘Bramlage P Schindler C 2010Expert Opin Pharmacother2010,11,4:1
8Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbld vascular disease: an analysis of the DiaRegis registry 显示文摘Gitt AK Bramlage P Binz C 2011Eur J Cardiovasc Prey Rehabil2011,,:1
9Role of the vasodilator peptide angiotensin-( 1 - 7 ) in cardiovascular drug therapy 显示文摘Schindler C Bramlage P Kirch W 2007Vasc Health and Risk Manag2007,3,1:1
10Role of the vasodilator peptide angiotensin-( 1 - 7 ) in cardiovascular drug therapy显示文摘Schindler C Bramlage P Kirch W 2007Vasc Health Risk Manag2007,3,1:1
11Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy显示文摘Schindler C Bramlage P Kirch W 2007Vase Health Risk Manag2007,3,1:1
12Differences in pharmacology and their translation into differences in clinical efficacy-a comparison of the renin angiotensin blocking agents irbesartan and losartan显示文摘Bramlage P Schindler C 2010Expert Opin Pharmacother2010,11,4:1
13Cultivar and growing region in uenceefcacy of warming treatments for amelioration of super cial scalddevelopment on apples after storage显示文摘WATKINS C B BRAMLAGE W J BROOKFIELD P L REID S J WEISS S A ALWAN T F 2000Postharvest Biology andTechnology2000,19,:1
14I-Iypoglycaemia is more frequent in type 2 diabetic patients with co-morbld vasculardisease: an analysis of the DiaRegis registry 显示文摘Gitt A K Bramlage P Binz C 2012Eur J Cardiovasc Prey Rehabil2012,19,4:1
15Oral antidiabetic treatmentin type-2 diabete's in the elderly: balancing the need for glu-cose control and the risk of hypoglycemia显示文摘Bramlage P Gitt AK Binz C 2012Cardiovavsc Dia-betol2012,6,11:1
16Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy显示文摘Schindler C Bramlage P Kirch W 2007Vasc Health Risk Manag2007,3,1:1
17Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis)-study protocol and patient characteristics at baseline显示文摘Bramlage P Binz C Gitt AK 2010Cardiovasc Diabetol2010,9,:1
18Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy显示文摘Schindier C Bramlage P Kirch W 2007Vasc Health Risk Manag2007,3,1:1
19Dys- lipidemia in primary care prevalence,recognition, treat- ment and control:date from the German Metabolic and Cardiovascular Risk Project (GEMCAS)显示文摘Steinhagen-Thiessen E Bramlage P Losch C 2008Cardiovasc Diabetol2008,7,:1
20Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation显示文摘Sander D Weimar C Bramlage P 2012BMC Neurol2012,12,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费